http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5998389-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a052db3ec138705a7f254d97767e09c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-579
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-579
filingDate 1998-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a18eed26fede63a73f5b2364bab27232
publicationDate 1999-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5998389-A
titleOfInvention Endotoxin-specific assay
abstract beta -1,4-glucans, particularly cellobiose, can be used to inhibit the glucan-specific enzymatic pathway in an amebocyte lysate. So inhibited, the amebocyte lysate can then be used to specifically detect endotoxin in a test sample. beta -1,4-glucan inhibitors can be used in a variety of amebocyte lysate assays, including kinetic-chromogenic, end-point chromogenic, turbidimetric, gel-clot, and ELISA assays.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007100250-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004162500-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004138577-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10023899-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005026239-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005069972-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007203424-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007073183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8491494-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008050144-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110628917-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013113296-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10844421-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7828741-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110628917-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005208614-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7547285-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8415117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004235195-A1
priorityDate 1998-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5155032-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0397880-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0330991-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5702882-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5641643-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5179006-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10712
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410650
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135794589
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46936190
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128006265

Total number of triples: 43.